Why Analysts Are Positive about Mondelēz Stock

Most analysts providing recommendations for Mondelēz International (MDLZ) have maintained a positive outlook on its stock. Analysts have a consensus rating of 2.1 on MDLZ on a scale of 1 (“strong buy”) to 5 (“strong sell”).

Moreover, of the 21 analysts tracking MDLZ, 77% have recommended “buys” on the stock as of July 26, 2017. Meanwhile, 23% have maintained “hold” recommendations on MDLZ. The company is currently trading 13.4% below analysts’ 12-month target price of $50.08.

Recently, Piper Jaffray upgraded its rating on Mondelēz stock to an “overweight” from a “neutral” and raised its target price for the stock to $49.00 from $48.00. Analyst Michael Lavery stated that favorable input costs stemming from lower cocoa and sugar prices and currency tailwinds were likely to boost the company’s profitability.

Mondelēz’s 2H17 results are likely to benefit from its planned innovation pipeline, which should help it to drive sales. Moreover, recovery in consumption in the United States (SPY) should supplement the company’s top line growth. 

Mondelēz’s focus on its Wellness segment through its new products, including belVita, GOOD THiNS, and Véa, and its stringent cost-control measures are expected to drive balanced top and bottom line growth in the coming quarters.

Analysts have an overall neutral outlook on The Hershey Company (HSY) stock. A total of 21% of the 19 analysts covering HSY have recommended “buys,” 68% have recommended “holds,” and 11% have recommended “sells” on the stock. 

A total of 14% of the 21 analysts covering The Kellogg Company (K) have recommended “buys” on the stock, 72% have recommended “holds,” and 14% have recommended “sells.”

Of the 19 analysts covering The Kraft Heinz Company (KHC), 74% have recommended “buys,” and 26% have recommended “holds” on the stock.